Connecticut Legislative Regulation Review Committee approved the removal of various controlled substance drugs, including Mitragyna Speciosa, also known as Kratom. These substances pose a significant public health risk, particularly to children, as they have been widely available for purchase by people of all ages, with no regulation, testing, or other public health protections. Kratom, which is sold in many different forms including pills, beverages, gummies and candy, powder and in its natural leaf form, currently has no approved medical use. It is not prescribed by physicians and is primarily available for purchase by people of all ages at gas stations and smoke shops, with no product testing, or other consumer protections.

Visit the 3/2026 DCP Press Release for more details: Lt Governor Bysiewicz, Attorney General Tong, DCP, DESPP, DMHAS Highlight Recent Controlled Substance Regulation Changes, Enforcement Efforts, Addiction Support